Clinical Trials Browser

Psoriasis × Adalimumab × Clear all

NCT02762955 2021-09-08

CALYPSO

Phase 3 Completed

Psoriasis

NCT02196701 2018-03-19

CLEAR

Phase 3 Completed

46 enrolled 27 charts

Psoriasis

NCT00932113 2017-08-31

MOA

Phase 4 Completed

33 enrolled 11 charts

Psoriasis

NCT02376478 2015-03-03

On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection

Psoriasis, Inflammatory Bowel Diseases